Variable findings have been reported for emotional processing in patients with Parkinson
disease (PD). These contradictions could be due to differences in the progression of …

Amygdala Activation Modulated by Levodopa During Emotional R... : Journal of Clinical
Psychopharmacology Amygdala Activation Modulated by Levodopa During Emotional …

In addition to classic motor signs and symptoms, Parkinson's disease (PD) is characterized
by neuropsychological and emotional deficits, including a blunted emotional response. In …

Dopamine (DA) acts as a key neurotransmitter in the brain. Numerous studies have shown
its regulatory role in motor and cognitive function. However, the impairment of emotional …

Parkinson's disease (PD) is associated with emotional abnormalities. Dopaminergic
medications ameliorate Parkinsonian motor symptoms, but less is known regarding the …

Some patients with advanced Parkinson's disease (PD) develop dose-related fluctuations in
mood. This may reflect alterations in dopamine-influenced brain circuits that mediate …

Emotional and cognitive impairments in Parkinson's disease (PD) are prevalent, hamper
interpersonal relations and reduce quality of life. It is however unclear to what extent these …

Deficits in emotional processing in patients with Parkinson's disease (PD) have received
increasing interest over the past decades. In this systematic review, we present the results of …

Depression is common in Parkinson's disease and is associated with cognitive impairment.
Dopaminergic medications are effective in treating the motor symptoms of Parkinson's …

Consistent with the hypothesis that dopamine is implicated in the processing of salient
stimuli relevant to the modification of various behavioral responses, Parkinson's disease is …